GENEPRO LIMITED

05298094
Active Plymouth

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
G

GENEPRO LIMITED

05298094

Research and experimental development on biotechnology

Founded 26 Nov 2004 Active Plymouth, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 21 Aug 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 20 Nov 2025 Next due 4 Dec 2026 5 months remaining
Net assets £10 £0 2024 year on year
Total assets £10 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Prospect Place West Hoe Plymouth Devon PL1 3DH

Full company profile for GENEPRO LIMITED (05298094), an active company based in Plymouth, United Kingdom. Incorporated 26 Nov 2004. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type dormant
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£10.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Christopher Clive MooresSecretaryUnknownUnknown4 Sept 2024Active
Julian Icarus AllenDirectorBritishEngland621 Oct 2019Active

Shareholders

Shareholders (1)

Pml Applications Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Pml Applications Ltd

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

PML APPLICATIONS LTD united kingdom
GENEPRO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Nov 2025Confirmation StatementConfirmation statement made on 20 Nov 2025 with no updates
21 Aug 2025AccountsAnnual accounts made up to 31 Mar 2025
28 Nov 2024Confirmation StatementConfirmation statement made on 26 Nov 2024 with no updates
4 Sept 2024AccountsAnnual accounts made up to 31 Mar 2024
4 Sept 2024OfficersTermination of Beverly Kim Tremain as director on 4 Sept 2024
20 Nov 2025 Confirmation Statement

Confirmation statement made on 20 Nov 2025 with no updates

21 Aug 2025 Accounts

Annual accounts made up to 31 Mar 2025

28 Nov 2024 Confirmation Statement

Confirmation statement made on 26 Nov 2024 with no updates

4 Sept 2024 Accounts

Annual accounts made up to 31 Mar 2024

4 Sept 2024 Officers

Termination of Beverly Kim Tremain as director on 4 Sept 2024

Recent Activity

Latest Activity

Confirmation statement made on 20 Nov 2025 with no updates

6 months ago on 20 Nov 2025

Annual accounts made up to 31 Mar 2025

9 months ago on 21 Aug 2025

Confirmation statement made on 26 Nov 2024 with no updates

1 years ago on 28 Nov 2024

Annual accounts made up to 31 Mar 2024

1 years ago on 4 Sept 2024

Termination of Beverly Kim Tremain as director on 4 Sept 2024

1 years ago on 4 Sept 2024